The application of genomics across the life sciences industry is currently challenged by an inadequate ability to interpret and act on genomic data quickly and accurately for a wide variety of applications. One challenge has been that of integrating market and thought leaders across what had historically been orthogonal industries: computing and biotechnology. With the advent of high-throughput sequencing technologies, those industries are now interdependent and have a critical need to synthesize and coordinate activities at the interface of computing and genomics.
The University of Illinois at Urbana-Champaign and Mayo Clinic as well as our affiliate, the University of Chicago, which are leading institutions in these areas and already have strong ties to each other, have established the Center for Computational Biotechnology and Genomic Medicine (CCBGM), a collaborative environment that will improve the applicability, timeliness, efficiency, and accuracy of the computational infrastructure that will address pressing genome-based challenges.
The mission of the CCBGM is to engineer and optimize computing systems needed by industry for genome analysis. In doing so, the CCBGM will enhance entrepreneurship, research, and education while developing technology that transforms the medical practice.
CCBGM in the News
Announcement of funding of the CCBGM:
- NSF Funds Two New CSL Industry/University Cooperative Research Centers
- Iyer Leads Search for New Computer Platform to Speed Genomic Data Interpretation
Each month, Catalyst, the Illinois Science & Technology Coalition’s monthly publication, features a column written by a leader from the tech community and highlights major Illinois science news stories.
See the March 2015 Catalyst in which the CCBGM was featured.